Nuvation Bio (NUVB) Jumps to 3-Year High on Bullish Coverage
In its first coverage for Nuvation Bio Inc. (NYSE:NUVB), B.
Nuvation Bio Inc. (NUVB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Decheng Capital Min Cui | 25,954,439 | $96,031,424 | 16.75% | |
| 2. | Laurion Capital Management Benjamin A. Smith | 9,705,532 | $35,910,468 | -6% | 0.62% |
| 3. | Millennium Management Israel Englander | 4,852,218 | $17,953,207 | -10% | 0.01% |
| 4. | Tang Capital Management Kevin C. Tang | 4,200,000 | $15,540,000 | +8% | 0.6% |
| 5. | Abrams Capital Management David Abrams | 3,811,513 | $14,102,598 | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.71 | 10,000 | $17,100.00 | 29,591 | 2025-06-18 | Filing | |
| $1.79 | 4,000 | $7,160.00 | 9,902 | 2025-06-17 | Filing | |
| $1.84 | 3,300 | $6,055.50 | 5,902 | 2025-06-16 | Filing | |
| $1.81 | 50,000 | $90,350.00 | 81,000 | 2025-06-16 | Filing | |
| $1.80 | 24,000 | $43,200.00 | 50,000 | 2025-06-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.00 | 10,000 | $80,000.00 | 18,000 | 2025-11-26 | Filing | |
| $7.50 | 10,000 | $75,000.00 | 18,000 | 2025-11-25 | Filing | |
| $7.23 | 300,000 | $2,168,100.00 | 0 | 2025-11-20 | Filing | |
| $7.23 | 69,051 | $499,031.58 | 0 | 2025-11-20 | Filing | |
| $7.00 | 20,000 | $140,074.00 | 18,000 | 2025-11-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 50,570,474 | $187,110,754 | 0.01% | |
| 2. | 24,604,159 | $91,035,389 | 0% | |
| 3. | 15,454,595 | $57,182,001 | 0% | |
| 4. | 8,831,089 | $32,675,029 | 14.69% | |
| 5. | 6,089,185 | $22,529,985 | 0% |
News See All
Nuvation Bio Inc. (NUVB) is a Buy at H.C. Wainwright on Cancer Drug Development Progress
Nuvation Bio Inc. (NYSE:NUVB) is a must-buy penny stock to buy now. On November 4, H.C. Wainwright analyst Robert Burns reiterated a Buy rating on the stock and set a $10 price target.
11 Must-Buy Penny Stocks to Buy Now
Markets have continued to rally, with the S&P 500 already up by about 15% for the year.
12 Best American Penny Stocks to Buy Right Now
The S&P 500 is set to outperform the Russell 2000 in annual performance for the 10th time over the past 12 years.
Nuvation Bio Inc. (NYSE:NUVB) Q3 2025 Earnings Call Transcript
Operator: Hello, and welcome to Nuvation Bio's Third Quarter 2025 Financial Results and Corporate Update Call. Today's call is being recorded, and a replay will be available.
Nuvation Bio Inc. (NUVB): A Bull Case Theory
We came across a bullish thesis on Nuvation Bio Inc. on wallstreetbets subreddit by asagi_lumina. In this article, we will summarize the bulls’ thesis on NUVB.
Nuvation Bio Inc. (NUVB) IBTROZI Showing Promise in Non-Small Cell Lung Cancer Trials
Nuvation Bio Inc. (NYSE:NUVB) is one of the best healthcare penny stocks to buy now.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB)
Nuvation Bio Inc. (NYSE:NUVB) is one of the top strong buy stocks under $5 to buy now. In a report released on August 8, Robert Burns from H.C. Wainwright reiterated a Buy rating on Nuvation Bio Inc.
15 Strong Buy Stocks Under $5 to Buy Now
On August 22, Tom Lee, head of research and chief investment officer of Fundstrat Capital, appeared on CNBC’s ‘Squawk on the Street’ to talk about what he thinks about Fed Chair Powell’s speech...
Hedge Fund Resource Center Billionaire Hedge Funds
